Europe And Japan Allergy Immunotherapy Market
- 2026 年市場規模
- USD 1,675.6 Mn
- 2033 年預估規模
- USD 2,894.4 Mn
- 年複合成長率 CAGR
- 8.4%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Europe And Japan Allergy Immunotherapy Market, By Treatment (Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT)), By Allergy Type (Allergy Rhinitis, Allergy Asthma, Pollen Allergies (Cedar, Brich, Oak, Others), Pet Allergy (Cats, Dogs, Other Pets), Birds Allergy, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (Europe and Japan)
報告摘要
Immunotherapy is a preventive treatment for allergic reactions which are caused by substances such as grass pollens, house dust mites and bee venom. While providing immunotherapy treatment to patients, the dose of the drug is gradually increased to which the person is allergic. Immunotherapy also reduces the inflammation that characterizes rhinitis and asthma. Allergy shots, also known as subcutaneous immunotherapy (SCIT), is the most commonly used immunotherapy and this is the only treatment available that actually changes the immune system, making it possible to prevent development of new allergies and asthma.
Market Dynamics
Market players are involved in research and development activities for development of drugs for allergy immunotherapy and this is expected to drive growth of the Europe and Japan allergy immunotherapy market, over the forecast period. For instance, in May 2018, Stallergenes Greer, a biopharmaceutical company, announced positive results for its phase III clinical trial which was carried out, in order to evaluate the efficacy and safety of its sublingual allergy immunotherapy tablet STAGR320, for the treatment of house dust mite.
Key players are engaged in receiving approvals for their drugs, from the regulatory authorities and this is expected to drive growth of the Europe and Japan allergy immunotherapy market, over the forecast period. For instance, in November 2018, Stallergenes Greer, a biopharmaceutical company, received approval from the U.S. Food and Drug Administration (US FDA), for the extension of the indication for Oralair, for the treatment of patients with grass pollen-induced allergic rhinitis.
Moreover, in September 2018, Torii Pharmaceutical Co., Ltd. announced that Japan’s Ministry of Health, Labour and Welfare had approved the New Drug Application (NDA) for the Japanese cedar sublingual allergy immunotherapy (SLIT) tablet, i.e, CEDARCURE.
Key features of the study
• This report provides an in-depth analysis of the Europe and Japan allergy immunotherapy market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the Europe and Japan allergy immunotherapy market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include Novartis International AG, Merck & Co., Inc., Aimmune Therapeutics, Inc., Regeneron Pharmaceuticals, Inc., HAL Allergy B.V., Stallergenes Greer, ALK-Abelló A/S, Allergy Therapeutics Plc, Torii Pharmaceutical Co., Ltd., DESENTUM OY
• Insights from this report would allow marketers and management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The Europe and Japan allergy immunotherapy market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Europe and Japan allergy immunotherapy market
Market Segmentation
• By Treatment Insights (Revenue, US$ Mn, 2020 - 2033)
o Subcutaneous Immunotherapy (SCIT)
o Sublingual Immunotherapy (SLIT)
• By Allergy Type Size Insights (Revenue, US$ Mn, 2020 - 2033)
o Allergy Rhinitis
o Allergy Asthma
o Pollen Allergies
Cedar
Birch
Oak
Others
o Pet Allergy
Cats
Dogs
Other Pets
o Birds Allergy
o Others
• By Distribution Channel Insights (Revenue, US$ Mn, 2020 - 2033)
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• By Region Insights (Revenue, US$ Mn, 2020 - 2033)
o Europe
U.K.
Germany
Italy
Spain
Denmark
Sweden
Poland
Belgium
Netherlands
Russia
Rest of Europe
o Japan
• Key Players
o ALK-Abelló
o Stallergenes Greer
o HAL Allergy Group
o Allergy Therapeutics
o Aimmune Therapeutics
o DBV Technologies
o Torii Pharmaceutical
o ASIT Biotech
o Inmunotek
o Laboratorios LETI Pharma
o ROXALL Medizin
o Merck KGaA
o Kyowa Kirin
o Shionogi & Co.
o Novartis International AG
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Treatment
Market Snapshot, By Allergy Type
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Opportunity
Regulatory Scenario
Industry Trend
o Merger and Acquisitions
o Key Developments
o Market Trends
o Recent Product Launch / Approval
o PEST Analysis
o Merger, Acquisition & Agreements
o Epidemiology
o Porter’s Five Force Analysis
o Value Chain Analysis
4. Europe and Japan Allergy Immunotherapy Market, By Treatment, 2020 – 2033, (US$ Mn)
o Introduction
Market Share Analysis, 2020 and 2033 (%)
Y-o-Y Growth Analysis, 2020 – 2033
Segment Trends
o Subcutaneous Immunotherapy (SCIT)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (US$ Mn)
o Sublingual Immunotherapy (SLIT)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (US$ Mn)
5. Europe and Japan Allergy Immunotherapy Market, By Allergy Type, 2020 – 2033, (US$ Mn)
o Introduction
Market Share Analysis, 2020 and 2033 (%)
Y-o-Y Growth Analysis, 2020 – 2033
Segment Trends
o Allergy Rhinitis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (US$ Mn)
o Allergy Asthma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (US$ Mn)
o Pollen Allergies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (US$ Mn)
o Cedar
o Birch
o Oak
o Others
o Pet Allergies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (US$ Mn)
o Cats
o Dogs
o Other Pets
o Birds Allergy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (US$ Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (US$ Mn)
6. Europe and Japan Allergy Immunotherapy Market, By Distribution Channel, 2020 – 2033, (US$ Mn)
o Introduction
Market Share Analysis, 2020 and 2033 (%)
Y-o-Y Growth Analysis, 2020 – 2033
Segment Trends
o Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (US$ Million)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (US$ Million)
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (US$ Million)
7. Europe and Japan Allergy Immunotherapy Market, By Region, 2020 – 2033, (US$ Mn)
o Introduction
Market Share Analysis, By Region, 2020 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2020–2033
Regional Trends
o Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 – 2033, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Allergy Type, 2020 – 2033, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 – 2033, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020 – 2033, (US$ Mn)
o U.K.
o Germany
o Italy
o Spain
o Denmark
o Sweden
o Poland
o Belgium
o Netherlands
o Russia
o Rest of Europe
o Japan
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 – 2033, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Allergy Type, 2020 – 2033, (US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 – 2033, (US$ Mn)
8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
ALK-Abelló
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Stallergenes Greer
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
HAL Allergy Group
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Allergy Therapeutics
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Aimmune Therapeutics
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
DBV Technologies
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Torii Pharmaceutical
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
ASIT Biotech
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Inmunotek
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Laboratorios LETI Pharma
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
ROXALL Medizin
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Merck KGaA
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Kyowa Kirin
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Shionogi & Co.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Novartis International AG
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
o Analyst Views
9. Section
o Research Methodology
o About us
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們